One of the mechanisms thought to be responsible for weight regain or plateau is a reduction in circulating levels of leptin after initial weight loss [11, 58]
Meanwhile, ADHD affects overall attention and behavior management
Routine medical review is advisable if: Light-headedness occurs frequently or predictably (e.g., after each injection) Symptoms develop after a dose increase and do not improve within one to two weeks You experience recurrent episodes of low blood glucose readings Light-headedness is associated with persistent nausea, vomiting, or diarrhoea You have concerns about medication interactions or other health conditions Your healthcare professional may need to adjust your Ozempic dose, review concomitant medications (particularly other diabetes treatments, antihypertensives, or diuretics), or investigate alternative causes
Most importantly, many described feeling more in control of their eating
Pfizer selects once-daily GLP-1 for its obesity push Pfizer is advancing on a broad front in its attempt to catch up with Novo Nordisk and Eli Lilly in the obesity drug category but has now decided on a lead candidate
Clinicians should note that these medications do not replace established therapies such as reninangiotensin system inhibitors or SGLT2 inhibitors